Fourth Angel

 

When diagnosed with testicular cancer in 1997, Olympic figure skating champion Scott Hamilton identified three "angels" who helped him in his successful fight. His oncology physician was his first angel; his oncology nurse was his second angel; and his family and friends were his third.

What he found missing, however, was a fourth angel—somone who had gone through the same experience and who understood what he was feeling. Someone, in short, who had "been there."

After beating his cancer, Scott set up the 4th Angel Mentoring Program.

Patient Mentors

The 4th Angel Program matches patients with a cancer survivor of a similar background and age who can offer advice and support. Anyone with cancer can be brought together with a mentor. Once a match is made, the mentor will then set up a phone or e-mail correspondence with the patient.

Caregiver Mentors

Mentors are also available for anyone caring for a cancer patient. A caregiver mentor is someone who is currently, or was previously, a caregiver for a cancer patient. 

Mentors call on their life experience to assist others in their journey through cancer. They offer comfort and reassurance to patients and family members, allowing them to express their feelings, talk about their fears, and ask questions of someone who has been in their situation.

For more information on being a patient or caregiver mentor, visit www.scottcares.com.

To have someone from the 4th Angel Network contact you regarding joining the program, please click here

 

 

 

Latest Cancer News
Vaccine Against HPV-16 Effective for Vulvar Intraepithelial Neoplasia

November 6, 2009 — Researchers from the Netherlands have reported that vaccination with synthetic long-peptides against human papillomavirus (HPV)-16 was effective in treating vulvar intraepithelial neoplasia (VIN). The details of this study were published in the November 5, 2009 issue of the New England Journal of Medicine.

Small HER2-positive Breast Cancers Have a Higher Risk of Recurrence

November 6, 2009 — Researchers from the M. D. Anderson Cancer Center and the University of Milan, Italy, have reported that women with Stage T1a,b, N0M0 HER2-positive breast cancers have a have a high recurrence rate without the administration of adjuvant chemotherapy or Herceptin® (trastuzumab). These data suggest that these women should be treated with Herceptin®-based adjuvant chemotherapy. The details of these two studies appeared in early online publications on November 2, 2009 in the Journal of Clinical Oncology.

Alcohol May Reduce Risk of Thyroid Cancer

November 6, 2009 — Researchers affiliated with the NIH-AARP Diet and Health Study have reported that alcohol intake may reduce the risk of thyroid cancer. The details of this study appeared in the November 4, 2009 issue of the British Journal of Cancer.

Select news items provided by Reuters Health
Other Support Groups